Pereira D, Pereira T G, Rabaçal C, Carvalho E, Linder J, Afonso J S, Pereira J N, Halpern M J, Fernandes J S
Serviço de Cardiologia do Hospital de Vila Franca de Xira, Portugal.
Rev Port Cardiol. 1990 Mar;9(3):205-10.
Fifty four patients (p) with acute myocardial infarction (40M; 14F) were entered into a prospective study where they received either intravenous magnesium sulphate (group A-27 p) or placebo (group B-27 p). The incidence of arrhythmias necessitating treatment was greater in group B (37%) than in group A (15%). Mortality was 18.5% in group B and 3.7% in group A. These results suggest that magnesium sulphate administration reduces the incidence of arrhythmias and death after acute myocardial infarction.
54例急性心肌梗死患者（40例男性，14例女性）进入一项前瞻性研究，他们被随机分为两组，分别接受静脉注射硫酸镁（A组，27例）或安慰剂（B组，27例）。需要治疗的心律失常发生率在B组（37%）高于A组（15%）。B组死亡率为18.5%，A组为3.7%。这些结果表明，急性心肌梗死后给予硫酸镁可降低心律失常的发生率和死亡率。
